OTCMKTS:ZLDPF Zealand Pharma A/S (ZLDPF) Stock Price, News & Analysis $129.24 -6.42 (-4.73%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$129.00▼$133.0850-Day Range$84.25▼$140.1952-Week Range$35.19▼$140.28Volume4,086 shsAverage Volume2,376 shsMarket Capitalization$6.66 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest Get Zealand Pharma A/S alerts: Email Address Ad DarwinTop Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.Get Your Free Report About Zealand Pharma A/S Stock (OTCMKTS:ZLDPF)Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.Read More ZLDPF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ZLDPF Stock News HeadlinesJuly 25 at 1:45 AM | americanbankingnews.comBrokers Set Expectations for Zealand Pharma A/S's FY2024 Earnings (OTCMKTS:ZLDPF)July 24 at 10:50 AM | businessinsider.com4 high-conviction stock picks from top ETF managers — including GMO and a fund up 90% since 2022July 26, 2024 | MarketBeat (Ad)We just added a $300 account credit to your MarketBeat subscriptionMarketBeat All Access is our complete suite of portfolio monitoring software, research tools, stock screeners, proprietary reports, and more. Upgrade today and get $300 off your 2024-2025 subscription. Free for 30 days.July 19, 2024 | finance.yahoo.comHere's What Could Help Zealand Pharma AS (ZLDPF) Maintain Its Recent Price StrengthJune 21, 2024 | cnbc.comWeight loss drug contender Zealand Pharma jumps 23% on trial resultsJune 20, 2024 | reuters.comZealand Pharma's drug reduces weight by 8.6% in early-stage studyJune 6, 2024 | reuters.comZealand Pharma says drug shows improvement in fatty liver disease patientsMay 27, 2024 | msn.com'Not just a harmless medicine': Pharmacist concerned about safety as pseudoephedrine back on shelvesJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 23, 2024 | marketwatch.comZealand Pharma Reports Low-Dose Results for New Obesity DrugMay 15, 2024 | markets.businessinsider.comZealand Pharma A-S is about to announce earnings — here's what Wall Street expectsMay 2, 2024 | msn.comExplainer: Does Zambia's bondholder deal mean it has resolved its default?May 1, 2024 | msn.comGovt's Pharmac funding boost 'doesn't go far enough', advocate saysApril 29, 2024 | msn.comPharmac's budget boosted to $6.3b over next four yearsApril 17, 2024 | msn.comAuckland to Northland expressway will boost GDP by $1.2b a year, report showsApril 17, 2024 | bloomberg.comA Double-Dip Recession in the Land of the Long White CloudApril 11, 2024 | msn.comAuckland's newest social supermarket officially opensApril 3, 2024 | markets.businessinsider.comUnveiling New Zealand's Most Deadly Urban Pest: A Comprehensive ExaminationSee More Headlines Receive ZLDPF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zealand Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/16/2024Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:ZLDPF Previous SymbolNASDAQ:ZLDPF CUSIPN/A CIKN/A Webwww.zealandpharma.com Phone45-8877-3600Fax45-8877-3898Employees340Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.82) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-102,180,000.00 Net Margins-213.77% Pretax Margin-215.55% Return on Equity-36.96% Return on Assets-30.10% Debt Debt-to-Equity Ratio0.10 Current Ratio12.30 Quick Ratio12.28 Sales & Book Value Annual Sales$49.75 million Price / Sales133.81 Cash FlowN/A Price / Cash FlowN/A Book Value$4.49 per share Price / Book28.78Miscellaneous Outstanding Shares51,510,000Free FloatN/AMarket Cap$6.66 billion OptionableNot Optionable Beta0.97 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Adam Sinding Steensberg M.D. (Age 50)President & CEO Comp: $1.73MMs. Henriette Wennicke (Age 41)EVP & CFO Comp: $706.47kMr. Ivan Mourits Moller (Age 52)Executive VP & COO Dr. David M. Kendall M.D. (Age 63)Chief Medical Officer and Head of R&D Mr. Mads KronborgHead of Investor Relations & CommunicationMr. Ravinder Singh Chahil (Age 56)EVP & General Counsel Ms. Christina Sonnenborg Bredal (Age 39)Executive VP & Chief People Officer Dr. Jens Damsgaard Mikkelsen M.D.Head of Molecular PharmacologyDr. Danilo VergeHead of Global Medical AffairsLykke RomerVP & Head of Finance and AccountingMore ExecutivesKey CompetitorsTeva Pharmaceutical IndustriesNYSE:TEVABeiGeneNASDAQ:BGNEDr. Reddy's LaboratoriesNYSE:RDYCatalentNYSE:CTLTQiagenNYSE:QGENView All Competitors ZLDPF Stock Analysis - Frequently Asked Questions How have ZLDPF shares performed this year? Zealand Pharma A/S's stock was trading at $55.65 at the beginning of 2024. Since then, ZLDPF stock has increased by 132.2% and is now trading at $129.2424. View the best growth stocks for 2024 here. How were Zealand Pharma A/S's earnings last quarter? Zealand Pharma A/S (OTCMKTS:ZLDPF) issued its quarterly earnings data on Thursday, May, 16th. The company reported ($0.54) earnings per share for the quarter. The company had revenue of $2.20 million for the quarter. Zealand Pharma A/S had a negative trailing twelve-month return on equity of 36.96% and a negative net margin of 213.77%. How do I buy shares of Zealand Pharma A/S? Shares of ZLDPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ZLDPF) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zealand Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Zealand Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZLDPF Stock Alerts